Acute toxicity in 260 patients with locally limited prostate cancer after conformal radiotherapy risk-adjusted up to 74 Gy:: Results of a multicenter phase-II study

被引:0
|
作者
Zimmermann, F
Geinitz, H
Wachter, S
Wachter-Gerstner, N
Goldner, G
Glocker, S
Feldmann, HJ
Becker, G
Bamberg, M
Pötter, R
Molls, M
机构
[1] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
[2] Univ Vienna, Klin Strahlentherapie & Biol, Vienna, Austria
[3] Univ Klin Tubingen, Abt Strahlentherapie Radiol, D-72074 Tubingen, Germany
[4] Klinikum Fulda, Klin Radioonkol Strahlentherapie, Fulda, Germany
[5] Klin Eichert Goppingen, Onkol Klin, Strahlentherapie Radiol Zent Inst, Goppingen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 21
页数:1
相关论文
共 40 条
  • [1] Preliminary results of a multicenter phase II study on conformal radiotherapy of prostate cancer with risk of adjusted dosage increase to 74 Gy
    Wachter, S
    Wachter-Gerstner, N
    Zimmermann, F
    Geinitz, H
    Goldner, G
    Glocker, S
    Feldmann, HJ
    Becker, G
    Bamberg, M
    Molls, M
    Pötter, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 40 - 40
  • [2] Acute toxicity in 260 patients with localised prostate cancer treated within a prospective multicenter phase-II trial with combined 3D conformal radiotherapy (CRT) up to 74 Gy ± neoadjuvant hormonal therapy (HT)
    Wachter, S
    Wachter-Gerstner, N
    Zimmermann, F
    Geinitz, H
    Goldner, G
    Glocker, S
    Feldmann, HJ
    Becker, G
    Bamberg, M
    Molls, M
    Pötter, R
    PROGRESS IN RADIO-ONCOLOGY VII, PROCEEDINGS, 2001, : 231 - 236
  • [3] Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study
    Maluta, S.
    Dall'oglio, S.
    Romano, M.
    Marciai, N.
    Pioli, F.
    Giri, M. G.
    Benecchi, P. L.
    Comunale, L.
    Porcaro, A. B.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2007, 23 (05) : 451 - 456
  • [4] Three-dimensional conformal risk-adapted Radiotherapy of localized Prostate Cancer with moderate Dose Escalation from 70 to 74 Gy: 10-Year Results of the prospective German-Austrian Phase-II-Multicenter Study
    Goldner, G.
    Bombosch, V.
    Becker, G.
    Glocker, S.
    Feldmann, H. J.
    Bamberg, M.
    Molls, M.
    Poetter, R.
    Wachter, S.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (01) : 117 - 118
  • [5] 10-Year-Results of the prospective German-Austrian Phase II Multicenter study for risk-adapted Radiotherapy of localized Prostate Cancer with a moderate Dose Escalation from 70 to 74 Gy
    Goldner, G.
    Bombosch, V.
    Becker, G.
    Wachter, S.
    Glocker, S.
    Feldmann, H.
    Bamberg, M.
    Poetter, R.
    Molls, M.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 37 - 38
  • [6] IMAGE-GUIDED HYPOFRACTIONATED RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER WITH 42 GY IN 7 FRACTIONS: RADIOBIOLOGY AND PRELIMINARY CLINICAL RESULTS OF A PHASE-II STUDY
    Magli, Alessandro
    Ceschia, Tino
    Titone, Francesca
    Isola, Miriam
    Vavassori, Vittorio
    Malisan, Maria Rosa
    Fongione, Sandro
    ANTICANCER RESEARCH, 2015, 35 (06) : 3644 - 3646
  • [7] Endoscopic evaluation of mucosal changes in the rectum preceding and 12 or 24 months following conformal radiotherapy for prostate cancer in a prospective multicenter phase-II study
    Goldner, G
    Wachter, S
    Wachter-Gerstner, N
    Zimmermann, F
    Geinitz, H
    Glocker, S
    Feldmann, HJ
    Becker, G
    Bamberg, M
    Molls, M
    Pötzi, R
    Pötter, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 46 - 46
  • [8] Health-related quality of life in patients with locally advanced prostate cancer after 76 GY intensity-modulated radiotherapy vs. 70 GY conformal radiotherapy in a prospective and longitudinal study
    Lips, Irene
    Dehnad, Human
    Kruger, Arto Boeken
    van Moorselaar, Jeroen
    van der Heide, Uulke
    Battermann, Jan
    van Vulpen, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 656 - 661
  • [9] Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer
    Zelefsky, MJ
    Kelly, WK
    Scher, HI
    Lee, H
    Smart, T
    Metz, E
    Schwartz, L
    Fuks, Z
    Leibel, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1936 - 1941
  • [10] Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: Results of a phase I/II study
    Konety, BR
    Eastham, JA
    Reuter, VE
    Scardino, PT
    Donat, SM
    Dalbagni, G
    Russo, P
    Herr, HW
    Schwartz, L
    Kantoff, PW
    Scher, H
    Kelly, WK
    JOURNAL OF UROLOGY, 2004, 171 (02): : 709 - 713